Results 1 to 10 of about 4,527,439 (244)

Severe Cutaneous Adverse Reaction Caused by Carbamazepine and Levofloxacin After Varicella Zoster Virus Infection [PDF]

Infection and Drug Resistance, 2023
Meifang Wang,* Li Lin,* Leyi Wang, Linfeng Li Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Linfeng Li ...
Wang M, Lin L, Wang L, Li L
doaj   +4 more sources

Causes of Drug-Induced Severe Cutaneous Adverse Reaction Epidermal Necrolysis (EN): An Analysis Using FDA Adverse Event Reporting System (FAERS) Database [PDF]

Clinical, Cosmetic and Investigational Dermatology, 2023
Weiqiang Fei,1 Jun Shen,2 Hui Cai3 1College of Nursing, Hangzhou Vocational & Technical College, Hangzhou, Zhejiang Province, People’s Republic of China; 2Nursing Department, Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine,
Fei W, Shen J, Cai H
doaj   +3 more sources

A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine [PDF]

JAAD Case Reports, 2021
Kristen Lospinoso, BS, Cameron S. Nichols, MD, Stephen J. Malachowski, MD, Mark C. Mochel, MD, Fnu Nutan, MD   +4 more
doaj   +4 more sources

Challenges in Diagnosis and Management of Cutaneous Adverse Drug Reaction [PDF]

Nepal Journal of Dermatology, Venereology & Leprology, 2020
Adverse drug reactions commonly involve the skin and represent a significant proportion of all drug‐induced illnesses. Most of the times, adverse cutaneous reactions are not severe and only a few are fatal.
Manish Pradhan
doaj   +4 more sources

Severe Cutaneous Adverse Reaction (SCAR): Clinical pharmacologists' viewpoint [PDF]

Indian Dermatology Online Journal, 2022
Nusrat Shafiq, Samiksha Bhattacharjee, Samir Malhotra   +2 more
doaj   +2 more sources

Target‐Specific Dermatological Adverse Event Reporting With T‐Cell–Engaging Bispecific Antibodies: A Pharmacovigilance Analysis of FAERS and Canada Vigilance, 2016–2026 [PDF]

Cancer Medicine
Background T‐cell–engaging bispecific antibodies are increasingly utilised in haematological malignancies and are beginning to be adopted in solid‐tumour treatment protocols.
Saikat Mandal, Manideepa Maji, Arkadeep Dhali   +2 more
doaj   +2 more sources

Severe cutaneous reactions to drugs in the setting of a general hospital [PDF]

Anais Brasileiros de Dermatologia, 2014
BACKGROUND: Cutaneous drug reactions are frequently found. Assessing the clinical and epidemiological profile of severe forms is extremely relevant for their better recognition and management. Few studies have assessed the severe forms of cutaneous drug
Luciana Rosa Grando, Tatiana Aline Berger Schmitt, Renato Marchiori Bakos   +2 more
doaj   +3 more sources

Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns [PDF]

Dermatology Practical & Conceptual
Introduction: IL-17 and IL-23 inhibitors have transformed the management of moderate-to-severe psoriasis and other inflammatory diseases through targeted immune modulation.
Ingyun Park, Ali Bayrouti, Duncan MacIntyre, Vivian Le, Khoa Nguyen   +4 more
doaj   +2 more sources

Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics

Frontiers in Pharmacology, 2022
SCARs are rare and life-threatening hypersensitivity reactions. In general, the increased duration of hospital stays and the associated cost burden are common issues, and in the worst-case scenario, they can result in mortality.
Therdpong Tempark, Therdpong Tempark, Shobana John, Shobana John, Pawinee Rerknimitr, Pawinee Rerknimitr, Patompong Satapornpong, Patompong Satapornpong, Chonlaphat Sukasem, Chonlaphat Sukasem, Chonlaphat Sukasem, Chonlaphat Sukasem, Chonlaphat Sukasem, Chonlaphat Sukasem   +13 more
doaj   +1 more source

Causative drugs for drug-induced cutaneous reactions in central China: a 608-case analysis, [PDF]

Anais Brasileiros de Dermatologia, 2020
Background: Reports regarding the causative drugs of drug-induced cutaneous adverse reactions in China are indistinct, such that different regions have reported the spectrum of drugs differs substantially in different clinical conditions.
Jun Zhao, Lei Hu, Lihua Zhang, Maosong Zhou, Lichen Gao, Lin Cheng   +5 more
doaj   +2 more sources